ARTICLE | Clinical News

Symadex: Phase I started

October 18, 2004 7:00 AM UTC

Xanthus began a dose-escalating, U.K. Phase I trial in 15-20 patients who will receive IV infusions of Symadex once a day for 5 consecutive days every 3 weeks. The compound is in another Phase I trial...